Proveris Scientific has announced the launch of a new collection system called Kinaero Cx that is designed for improved sample collection consistency during MDI testing. The new system, which includes the company's Vereo automated actuator technology, controls parameters for inhaler shaking and actuation, shake-to-fire timing, and flow rate and can be used for both … [Read more...] about Proveris Scientific launches Kinaero Cx collection system for automated MDI testing
Products and Services
DFE Pharma, Sterling, and Harro Höfliger partner as “INTO” to offer DPI development services
Inhaled lactose manufacturer DFE Pharma, API manufacturer Sterling, and filling/packaging company Harro Höfliger have partnered to create an early development service for DPIs called "INTO" (Inhalation Together). According to the INTO web site, the partnership will offer API development and characterization services, pre-formulation and formulation studies, and … [Read more...] about DFE Pharma, Sterling, and Harro Höfliger partner as “INTO” to offer DPI development services
Sandoz acquires inhaler developer Coalesce Product Development
Declaring that it is "determined to grow its portfolio in the complex generics space," Novartis generics division Sandoz announced its acquisition of device device developer Coalesce Product Development. Coalesce's inhaler technology include MDI, breath-actuated MDI, and DPI platforms. Sandoz said that it "sees respiratory as a key pillar of its ambitious long-term … [Read more...] about Sandoz acquires inhaler developer Coalesce Product Development
Adherium submits 510(k) for Hailie sensor to be used with Ellipta DPIs
Inhaler monitoring company Adherium has announced the submission of a 510(k) for a new Hailie sensor designed specifically for use with Ellipta DPIs. In September 2021, the FDA cleared another version of the next generation Hailie sensor for use with Symbicort MDIs. The sensors, which snap on to the outside of the device, connect to a cloud-based monitoring platform … [Read more...] about Adherium submits 510(k) for Hailie sensor to be used with Ellipta DPIs
HCmed, Formosa Laboratories, and Formosa Pharmaceuticals partner on new inhalation CDMO
Device maker HCmed Innovations has partnered with Formosa Laboratories and Formosa Pharmaceuticals to offer contract development and manufacturing services for inhaled drugs, HCmed announced. Formosa Laboratories already offers CDMO services for pharmaceutical products; the new services will also incorporate Formosa Pharmaceutical's nanotechnology platform and HCmed's … [Read more...] about HCmed, Formosa Laboratories, and Formosa Pharmaceuticals partner on new inhalation CDMO
Broughton launches US subsidiary
Broughton, a CRO that offers development and analysis of inhaled drugs, especially nicotine and cannabinoid products, has announced the establishment of a US subsidiary. Tony Jones, who has most recently been Senior Managing Health Scientist at consulting firm Cardno Chemrisk, was named Managing Consultant of the new business. Jones commented, "I am delighted to be … [Read more...] about Broughton launches US subsidiary
TFF Pharmaceuticals partners with Catalent for DPI development and manufacturing
TFF Pharmaceuticals has partnered with CDMO Catalent for scale-up and manufacturing of dry powder formulations based on TFF's thin film freezing technology the companies have announced. The partnership will make the TFF technology available to other Catalent clients as well. Catalent notes that the TFF technology is its second addition to its inhaled dry powder … [Read more...] about TFF Pharmaceuticals partners with Catalent for DPI development and manufacturing
Kindeva announces second lower-GWP MDI manufacturing line
CDMO Kindeva Drug Delivery has announced that it will invest in a second MDI manufacturing line capable of filling lower global warming potential (GWP) propellants such as HFA 152a and HFO 1234ze in response to increasing demand. The company announced plans to install its first lower-GWP propellant filling line in November 2021. The new line is expected to be … [Read more...] about Kindeva announces second lower-GWP MDI manufacturing line
AstraZeneca partners with Honeywell on development of HFO-1234ze MDIs
AstraZeneca has announced a partnership with Honeywell for development of lower global warming potential MDIs using HFO-1234ze as a propellant. The company said that Breztri budesonide/ glycopyrronium/ formoterol fumarate is the first product it plans to convert to HFO-1234ze and that a Phase 1 trial of an HFO 1234ze formulation of budesonide/ glycopyrronium/ … [Read more...] about AstraZeneca partners with Honeywell on development of HFO-1234ze MDIs
Aptar Pharma breaks ground on new manufacturing facility in Mumbai
OINDP device manufacturer Aptar Pharma recently broke ground on new manufacturing facility on a 3.5 acre site in Mumbai, India, with the groundbreaking taking place on the tenth anniversary of the existing Aptar facility in Mumbai, the company said. Construction on the new facility is expected to be complete by the first quarter of 2023. The existing facility, … [Read more...] about Aptar Pharma breaks ground on new manufacturing facility in Mumbai